What is the recommended dosing for Orapred (prednisolone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing for Orapred (Prednisolone)

The recommended dosing for Orapred (prednisolone) ranges from 5 to 60 mg per day depending on the specific condition being treated, with initial dosing typically individualized based on disease severity and patient response. 1

General Dosing Guidelines

  • The initial dose of prednisolone may vary from 5 to 60 mg per day depending on the specific disease entity being treated 1
  • For less severe conditions, lower doses generally suffice, while selected patients may require higher initial doses 1
  • Dosage should be maintained or adjusted until a satisfactory response is noted, with subsequent gradual dose reduction to determine the lowest effective maintenance dose 1

Disease-Specific Dosing

Autoimmune Hepatitis

  • Initial treatment: 30 mg/day prednisolone, reducing to 10 mg/day over 4 weeks, plus azathioprine 1 mg/kg/day 2
  • Higher initial doses (up to 1 mg/kg/day) may be used for more rapid normalization of transaminases 2
  • For maintenance, if tolerated, treatment with prednisolone 5-10 mg/day should continue for at least 2 years 2

Nephrotic Syndrome

  • For children: 60 mg/m² or 2 mg/kg/day (maximum 60 mg/day) as a single daily dose for 4-6 weeks 2
  • Followed by alternate-day dosing at 40 mg/m² or 1.5 mg/kg (maximum 40 mg on alternate days) for 2-5 months with tapering 2
  • For relapses: Daily prednisolone until remission for at least 3 days, followed by alternate-day prednisolone for at least 3 months 2

Bullous Pemphigoid

  • Severe involvement: 0.75-1 mg/kg/day 2
  • Moderate disease: 0.3 mg/kg/day 2
  • Mild/localized disease: 0.5 mg/kg/day 2
  • Tapering: Reduce dose at fortnightly intervals, initially by one-third or one-quarter down to 15 mg daily, then by 2.5 mg decrements to 10 mg daily, followed by 1 mg monthly reductions 2

Asthma Exacerbations

  • For acute exacerbations in children: 1-2 mg/kg/day (maximum 60 mg/day) as a short course or "burst" therapy 2
  • Continue until peak expiratory flow rate reaches 80% of personal best or symptoms resolve (typically 3-10 days) 2
  • No evidence that tapering the dose after improvement prevents relapse 2

Pediatric Dosing

  • Initial doses range from 0.14 to 2 mg/kg/day in three or four divided doses (4 to 60 mg/m²/day) 1
  • For nephrotic syndrome: 60 mg/m²/day in three divided doses for 4 weeks, followed by 4 weeks of single-dose alternate-day therapy at 40 mg/m²/day 1
  • For asthma uncontrolled by inhaled corticosteroids and long-acting bronchodilators: 1-2 mg/kg/day in single or divided doses 1

Administration Considerations

  • Prednisolone is typically administered as a single daily dose 2
  • For long-term therapy, alternate-day dosing may help reduce adverse effects 2
  • If treatment is to be discontinued after long-term therapy, gradual withdrawal is recommended rather than abrupt cessation 1

Special Considerations and Precautions

  • Monitor patients regularly during therapy, with intervals of 1-6 months depending on level of control and treatment required 2
  • Consider step-down in therapy once the condition is well-controlled for at least 3 months 2
  • Calcium and vitamin D supplementation should be provided to patients on long-term steroid therapy 2
  • Bone DEXA scanning should be performed at 1-2 yearly intervals for patients on long-term steroids 2
  • Consider corticosteroid-sparing agents for patients requiring long-term therapy, especially in children and elderly patients 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prednisone Dosing Guidelines for Specific Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.